Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B

Song-Mei Lou1, You-Ming Li, Kai-Ming Wang

  • 1Department of Gastroenterology, Hangzhou First People's Hospital, Hangzhou 310006, Zhejiang Province, China. lousm_72@hotmail.com

Insights

Platelet-derived growth factor-BB (PDGF-BB) expression correlates with liver inflammation and fibrosis in chronic hepatitis B. This suggests PDGF-BB may contribute to the development and progression of liver fibrosis.

Area of Science:

  • Hepatology
  • Oncology
  • Immunology

Background:

  • Chronic hepatitis B is a significant cause of liver disease worldwide.
  • Liver fibrosis is a key pathological process in chronic hepatitis B, potentially leading to cirrhosis and hepatocellular carcinoma.
  • Platelet-derived growth factor-BB (PDGF-BB) is a potent mitogen and signaling molecule implicated in tissue repair and fibrosis.

Purpose of the Study:

  • To investigate the association between PDGF-BB expression and fibrogenesis in patients with chronic hepatitis B.
  • To determine if PDGF-BB levels correlate with histological findings of inflammation and fibrosis.
  • To explore the relationship between tissue PDGF-BB expression and specific biomarkers of fibrosis in circulation.

Main Methods:

  • Hepatic tissue samples from 43 chronic hepatitis B patients were analyzed.
  • Histological assessment included HE and picric acid-sirius red staining for inflammation and fibrosis.
  • Immunohistochemistry quantified PDGF-BB expression; serum levels of hyaluronic acid, pro-collagen III, collagen IV, and laminin were measured by RIA.

Main Results:

  • PDGF-BB expression showed a significant positive correlation with inflammatory activity (tau=0.58) and fibrosis stage (tau=0.55) in liver tissue.
  • Tissue PDGF-BB levels were also positively correlated with serum concentrations of hyaluronic acid (r=0.52), pro-collagen III (r=0.32), collagen IV (r=0.40), and laminin (r=0.33).
  • These findings indicate a strong link between PDGF-BB and fibrotic processes in chronic hepatitis B.

Conclusions:

  • PDGF-BB expression is closely associated with liver inflammation and fibrosis in chronic hepatitis B.
  • The results suggest that PDGF-BB plays a role in the pathogenesis and advancement of liver fibrosis.
  • Targeting PDGF-BB may represent a potential therapeutic strategy for managing liver fibrosis in chronic hepatitis B.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...